The reiteration of an Outperform rating and maintenance of a high price target by a reputable analyst like Kostas Biliouris from BMO Capital is likely to instill confidence among investors and could lead to a positive short-term impact on Korro Bio's stock price. The specific mention of a $120 price target suggests a strong bullish outlook on the stock, which could influence investor sentiment positively.